NuSkin Enterprises (NUS)
NYSE Pasaran dibuka
Nu Skin Enterprises, Inc. is a global beauty and wellness company that develops, markets, and sells personal care products, nutritional supplements, and related consumer technologies. The company is best known for the Nu Skin brand, which spans skin care, beauty devices, and anti-aging products, and Pharmanex, its wellness and nutrition line. Its products are distributed internationally through a direct selling model supported by independent sales leaders, social commerce tools, and local market operations.
Nu Skin reports its business across a broad geographic footprint that includes the Americas, Mainland China, Southeast Asia/Pacific, Japan, South Korea, Europe & Africa, and Hong Kong/Taiwan. This structure reflects the company’s reliance on local consumer preferences, regulatory environments, and distributor networks in each region. The Americas segment is a particularly important contributor, and wellness products represent a major part of total revenue.
Beyond its core branded consumer business, Nu Skin operates Rhyz, a strategic investment and operating platform. Rhyz includes manufacturing and packaging assets that support product development and supply chain capabilities, as well as other investments intended to broaden the company’s commercial reach. This gives Nu Skin exposure not only to consumer-facing beauty and wellness categories, but also to parts of the production infrastructure behind them.
The company competes in markets shaped by health-conscious consumers, premium skin care demand, and the growth of digital selling. Its performance depends on product innovation, brand engagement, distributor productivity, and the ability to navigate changing rules for direct selling and consumer products across global markets.
Dikemas kini terakhir
- Permodalan pasaran
- 256.35M
- Nisbah P/E
- 4.7
- Nisbah P/FCF
- 6.17
- Nisbah P/S
- 0.18
- Nilai perusahaan
- 281.29M
- Sektor
- Health Care
- Industri
- Drugs, Drug Proprietaries, and Druggists' Sundries
- Alamat
- 75 WEST CENTER ST, PROVO, UT, 84601
Global Derma Roller Market Size To Worth USD 668.17 Million By 2033 | CAGR OF 8.22%
Nu Skin (NUS) Up 5.6% Since Last Earnings Report: Can It Continue?
Nu Skin (NUS) Q1 Earnings Beat, Revenues Hurt by Currency Woes
Nu Skin Enterprises (NUS) Surpasses Q1 Earnings Estimates
Why Is Inter Parfums (IPAR) Down 4.1% Since Last Earnings Report?
Nu Skin (NUS) Down 7.2% Since Last Earnings Report: Can It Rebound?
Nu Skin (NUS) Q4 Earnings Top Estimates, Revenues Decline Y/Y
Nu Skin Enterprises (NUS) Surpasses Q4 Earnings and Revenue Estimates
Things to Consider Ahead of Nu Skin's (NUS) Q4 Earnings
Philip Morris (PM) Lags Q4 Earnings Estimates
Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for
Nu Skin (NUS) Down More Than 20% in 3 Months: Here's Why
Why Is Inter Parfums (IPAR) Up 2.8% Since Last Earnings Report?
Nu Skin (NUS) Up 1% Since Last Earnings Report: Can It Continue?
Nu Skin (NUS) Misses Q3 Earnings Estimates, Lowers Guidance
Why Nu Skin (NUS) Could Beat Earnings Estimates Again
e.l.f. Beauty (ELF) Readies for Q2 Earnings: Is a Beat Likely?
Things to Note Ahead of Nu Skin's (NUS) Q3 Earnings
Nu Skin Enterprises (NUS) Reports Next Week: Wall Street Expects Earnings Growth
Nu Vision 2025 Strategy Aids Nu Skin (NUS), High Costs Hurt
- Permodalan pasaran
Permodalan pasaran ialah jumlah nilai saham syarikat, dikira dengan mendarabkan harga saham dengan bilangan saham belum jelas.
- 256.35M
- Nilai perusahaan
Nilai perusahaan ialah jumlah nilai syarikat, termasuk permodalan pasaran, hutang dan tunai.
- 281.29M
- Nisbah P/E
Nisbah P/E membandingkan harga saham dengan pendapatan sesaham.
- 4.7
- Nisbah P/B
Nisbah P/B membandingkan harga saham dengan nilai buku sesaham.
- 0.32
- Nisbah P/S
Nisbah P/S membandingkan harga saham dengan hasil sesaham.
- 0.18
- NP / EBITDA
NP/EBITDA mengukur nilai syarikat berbanding pendapatan sebelum faedah, cukai, susut nilai dan pelunasan.
- 2.13
- NP / jualan
NP/jualan mengukur nilai syarikat berbanding jumlah hasil.
- 0.2
- Pendapatan sesaham
- 1.12
- Hasil dividen
Hasil dividen menunjukkan berapa banyak syarikat membayar dividen setahun berbanding harga saham.
- 7.1%
- Nisbah P/FCF
Nisbah harga kepada aliran tunai bebas membandingkan harga saham dengan tunai yang dijana selepas perbelanjaan dan pelaburan.
- 6.17
- Nisbah P/CF
Nisbah P/CF membandingkan harga saham dengan aliran tunai daripada operasi.
- 3.37
- Aliran tunai bebas
Aliran tunai bebas ialah tunai yang tinggal selepas kos operasi dan perbelanjaan modal.
- 41.57M
- Pulangan ekuiti
Pulangan ekuiti mengukur sejauh mana syarikat menggunakan ekuiti pemegang saham untuk menjana keuntungan.
- 6.87%
- Pulangan aset
Pulangan aset mengukur sejauh mana syarikat menggunakan asetnya untuk menjana keuntungan.
- 3.96%
- Hutang / ekuiti
Nisbah hutang kepada ekuiti membandingkan jumlah hutang syarikat dengan ekuiti pemegang saham.
- 0.28
- Nisbah semasa
Nisbah semasa mengukur keupayaan syarikat membayar hutang jangka pendek menggunakan aset semasa.
- 2.03
- Nisbah cepat
Nisbah cepat mengukur keupayaan membayar hutang jangka pendek menggunakan tunai dan aset lain yang mudah dicairkan.
- 1.34
- Nisbah tunai
Nisbah tunai mengukur keupayaan menampung hutang jangka pendek hanya dengan tunai dan setara tunai.
- 0.77
- Volum purata
Volum purata menunjukkan purata bilangan saham didagangkan dalam 30 hari dagangan terakhir dan menunjukkan kecairan.
- 631.2K
- Harga rujukan asas kewangan
Harga rujukan asas kewangan ialah harga saham yang digunakan semasa mengira nisbah dan metrik kewangan syarikat.
- 5.28
Penyata pendapatan
| Perkara | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Hasil | 320.61M | 370.32M | 364.21M | 386.14M | 364.49M |
| Keuntungan kasar | 214.46M | 261.98M | 256.72M | 265.73M | 246.96M |
| Pendapatan operasi | 4.03M | 23.24M | 21.64M | 30.78M | -9.9M |
| Pendapatan sebelum susut nilai | 18.21M | 36.16M | 33.73M | 43.83M | 29.42M |
| Pendapatan bersih | 1.84M | 14.49M | 17.08M | 21.12M | 107.52M |
| Pendapatan sesaham asas | 0.04 | 0.31 | 0.35 | 0.43 | 2.16 |
| Pendapatan sesaham dicairkan | 0.04 | 0.27 | 0.34 | 0.43 | 2.14 |
Kunci kira-kira
| Perkara | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Jumlah aset | 1.38B | 1.41B | 1.42B | 1.44B | 1.39B |
| Jumlah liabiliti | 582.71M | 600.07M | 624.61M | 655.94M | 637.44M |
| Jumlah ekuiti | 794.09M | 805.24M | 799.8M | 787.75M | 753.97M |
| Tunai dan setara | 198.65M | 238.63M | 251.79M | 264.16M | 203.77M |
| Aset semasa | 522.89M | 547.7M | 548.14M | 571.55M | 524.86M |
| Liabiliti semasa | 257M | 263.73M | 254.44M | 283.91M | 260.3M |
Aliran tunai
| Perkara | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Aliran tunai operasi | -3.92M | 16.62M | 27.48M | 35.8M | 389K |
| Aliran tunai pelaburan | -14.29M | -9.76M | -9.92M | 8.79M | 181.54M |
| Aliran tunai pembiayaan | -20.4M | -18.5M | -26.88M | 9.27M | -166.3M |
| Perubahan tunai | -39.98M | -13.16M | -12.37M | 60.39M | 16.89M |
| Jenis | Penyerahan | Tarikh | Pautan |
|---|---|---|---|
| edgar index | 144 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | S-8 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 144 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| eight k text | 8-K — 8-K | Lihat penyerahan | |
| edgar index | SD — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | SCHEDULE 13G/A — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 144 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| form 4 | Form 4 — Nathanson Laura | Lihat penyerahan | |
| edgar index | 10-Q — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| eight k text | 8-K — 8-K | Lihat penyerahan | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| eight k text | 8-K — 8-K | Lihat penyerahan | |
| edgar index | DEF 14A — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | DEFA14A — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | ARS — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 3 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| form 3 | Form 3 — Lantz Chelsea K | Lihat penyerahan | |
| edgar index | SCHEDULE 13G/A — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| eight k text | 8-K — 8-K | Lihat penyerahan | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| eight k text | 8-K — 8-K | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| form 4 | Form 4 — WOODBURY EDWINA D | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| eight k text | 8-K — 8-K | Lihat penyerahan | |
| form 4 | Form 4 — NAPIERSKI RYAN S | Lihat penyerahan | |
| form 4 | Form 4 — Thomas James D | Lihat penyerahan | |
| form 4 | Form 4 — Clark Chayce David | Lihat penyerahan | |
| form 4 | Form 4 — Hatchett Steven Keith | Lihat penyerahan | |
| form 4 | Form 4 — Keisel Justin S | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| form 4 | Form 4 — NAPIERSKI RYAN S | Lihat penyerahan | |
| form 4 | Form 4 — Thomas James D | Lihat penyerahan | |
| form 4 | Form 4 — Clark Chayce David | Lihat penyerahan | |
| form 4 | Form 4 — Hatchett Steven Keith | Lihat penyerahan | |
| form 4 | Form 4 — Keisel Justin S | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| form 4 | Form 4 — NAPIERSKI RYAN S | Lihat penyerahan | |
| form 4 | Form 4 — Thomas James D | Lihat penyerahan | |
| form 4 | Form 4 — Clark Chayce David | Lihat penyerahan | |
| form 4 | Form 4 — Hatchett Steven Keith | Lihat penyerahan | |
| form 4 | Form 4 — Keisel Justin S | Lihat penyerahan | |
| edgar index | 10-K — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| ten k section | 10-K — business | Lihat penyerahan | |
| ten k section | 10-K — mda | Lihat penyerahan | |
| ten k section | 10-K — risk_factors | Lihat penyerahan | |
| edgar index | SCHEDULE 13G — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Lihat penyerahan | |
| eight k text | 8-K — 8-K | Lihat penyerahan | |
| form 4 | Form 4 — NAPIERSKI RYAN S | Lihat penyerahan | |
| form 4 | Form 4 — NAPIERSKI RYAN S | Lihat penyerahan | |
| form 4 | Form 4 — Thomas James D | Lihat penyerahan | |
| form 4 | Form 4 — Thomas James D | Lihat penyerahan |